Methods of using death receptor ligands and CD20 antibodies

Details for Australian Patent Application No. 2005282397 (hide)

Owner Genentech, Inc.

Inventors Ashkenazi, Avi J.

Agent Griffith Hack

Pub. Number AU-A-2005282397

PCT Pub. Number WO2006/029275

Priority 60/607,834 08.09.04 US; 60/666,550 30.03.05 US

Filing date 7 September 2005

Wipo publication date 16 March 2006

International Classifications

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 35/02 (2006.01) Antineoplastic agents

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

8 March 2007 PCT application entered the National Phase

  PCT publication WO2006/029275 Priority application(s): WO2006/029275

31 March 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005282398-OFDM position location signaling utilizing mutually exclusive subsets of subcarriers

2005282396-Minimal thickness bone plate locking mechanism